Gemtuzumab Ozogamicin Ozogamicin represents a important advance in the treatment of severe blood cancer, mainly severe myeloblastic leukemia (AML). This particular antibody-drug combines a humanized immunoglobulin https://www.targetmol.com/compound/gemtuzumab